Melbourne, Australia

Kim Rice

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pyc Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kim Rice. Retrieved from https://idiyas.com/inventor/kim-rice

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kim Rice - Innovator in Optic Atrophy Treatment

Introduction

Kim Rice is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of medical treatments, particularly focusing on optic atrophy. His innovative work has led to the development of a patent that addresses this critical health issue.

Latest Patents

Kim Rice holds a patent for the "Treatment of Optic Atrophy." This patent represents a significant advancement in the medical field, providing new hope for individuals affected by this condition. The patent showcases his dedication to improving patient outcomes through innovative solutions.

Career Highlights

Kim Rice is currently associated with Pyc Therapeutics Limited, where he continues to work on groundbreaking research and development. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to medical science.

Collaborations

Kim has worked alongside notable colleagues, including Ianthe Pitout and Sasiwimon Utama. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, ultimately leading to more effective treatments.

Conclusion

In summary, Kim Rice is a dedicated inventor whose work in the treatment of optic atrophy has the potential to change lives. His innovative spirit and commitment to medical advancements make him a valuable asset to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…